Outcome and Cost of Optimal Control of Dyslipidemia in Adults with High Risk for Cardiovascular Disease

Summary: We examined the association between optimal control of dyslipidemia and mortality and healthcare costs in patients with high risk for cardiovascular disease (HRCVD) between 2012-2016 in Alberta, Canada. HRCVD patients who were optimally controlled had lower mortality and incurred modestly higher costs, compared to those who were not. Secondary prevention patients with optimal control of dyslipidemia experienced lower mortality at no additional costs, thereby highlighting the benefit of targeted treatment strategies on the most high-risk population.

Publication Type: Journal Articles

Year of Publication: 2020

Topics: Chronic Diseases / Disorders, Health Economics / Healthcare Costs

Authors: Dat Tran, Dan Palfrey, Thomas Lo, Robert Welsh

Journal Title: Canadian Journal of Cardiology